Can-Fite BioPharma Ltd. (CANF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Can-Fite BioPharma Ltd.

    AMEX: CANF · Real-Time Price · USD
    0.63
    0.02 (3.26%)
    At close: Sep 26, 2025, 3:59 PM
    0.63
    0.00%
    After-hours: Sep 26, 2025, 03:59 PM EDT

    Can-Fite BioPharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 674K 743K 810K 853K
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 674K 743K 810K 853K
    Operating Income
    		 -8.13M -8.2M -10.1M -12.84M
    Interest Income
    		 291K 506K 222K 24K
    Pretax Income
    		 -7.88M -7.63M -10.17M -12.62M
    Net Income
    		 -7.88M -7.63M -10.53M -12.6M
    Selling & General & Admin
    		 3.05M 2.96M 3.14M 3.85M
    Research & Development
    		 5.76M 5.98M 7.76M 9.85M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 8.8M 8.94M 10.91M 13.7M
    Interest Expense
    		 14K 14K 16K 18K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 8.8M 8.94M 10.91M 13.7M
    Income Tax Expense
    		 n/a n/a 360K -20K
    Shares Outstanding (Basic)
    		 7.25M 4.26M 2.72M 1.53M
    Shares Outstanding (Diluted)
    		 7.25M 4.26M 2.72M 1.84M
    EPS (Basic)
    		 -1.08 -1.8 -3.75 -8.25
    EPS (Diluted)
    		 -1.08 -1.8 -3.75 -8.25
    EBITDA
    		 -8.12M -8.18M -10.08M -12.83M
    EBIT
    		 -8.13M -8.2M -10.1M -12.84M
    Depreciation & Amortization
    		 7K 15K 14K 14K

    Add to Watchlist